Beta Bionics, Inc. Common Stock (BBNX)
Healthcare
Medical Devices
—
12.80 $
-10.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Beta Bionics, Inc. Common Stock (BBNX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 56.9% of the shares are freely tradable; institutional investors hold 112.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
112.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
56.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
10.5%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
45Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Asset Management, LLC | 13.34 | 5,945,488 | +19.0 | 03/31/2026 |
| Soleus Capital Management, L.P. | 9.77 | 4,354,501 | +71.8 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 9.49 | 4,227,634 | +22.2 | 03/31/2026 |
| Sands Capital Ventures, LLC | 8.32 | 3,708,043 | +3.9 | 03/31/2026 |
| Farallon Capital Management, L.L.C. | 8.10 | 3,607,920 | -16.4 | 03/31/2026 |
| BlackRock Inc | 6.82 | 3,038,595 | +4.3 | 03/31/2026 |
| Point72 Asset Management, L.P. | 5.67 | 2,525,040 | +155.7 | 03/31/2026 |
| Vanguard Group Inc | 4.98 | 2,218,238 | +0.1 | 12/31/2025 |
| Vestal Point Capital LP | 4.96 | 2,211,518 | +268.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Gilead N | 8.42 | 3,750,973 | +27.3 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.